Given this evidence, a melatonin-mediated targeting of the NLRP3 axis may be a promising approach to preventing TAM-regulated angiogenesis and lymphangiogenesis in lung adenocarcinoma. Here, NLRP3 is linked to lung adenocarcinoma.